ONC BeOne Medicines Ltd.: institutional ownership and insider trading
306 funds reported holding $10.1B of BeOne Medicines Ltd. in their latest 13F filings; in Q2 2026 funds net bought $27.2M, with 42 new positions and 42 funds selling out; over the last 12 months insiders bought $0 and sold $380M on the open market.
Famous investors holding ONC
- Izzy Englander (Millennium Management): $162M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $81.7M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $412M, 0.1% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $29.1M, 0.0% of the portfolio
Largest institutional holders of ONC
- BAKER BROS. ADVISORS LP — $2.51B
- PRIMECAP MANAGEMENT CO/CA/ — $1.43B
- Capital International Investors — $1.20B
- FMR LLC — $706M
- Capital World Investors — $641M
- CITADEL ADVISORS LLC — $412M
- Temasek Holdings (Private) Ltd — $241M
- PRICE T ROWE ASSOCIATES INC /MD/ — $216M
- BlackRock, Inc. (BLK) — $198M
- MILLENNIUM MANAGEMENT LLC — $162M
Recent ONC insider trades
- Oct 13, 2026: Wang Xiaodong sold 31,027 shares ($10.9M)
- Sep 30, 2026: Lee Chan Henry sold 1,115 shares ($418K)
- Sep 28, 2026: Wang Xiaodong sold 31,028 shares ($11.3M)
- Sep 8, 2026: Wang Xiaodong sold 38,287 shares ($13.4M)
5%+ owners
- Julian C. Baker: 7.8% (Schedule 13D/A, filed Sep 16, 2026)